Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)

被引：0
|
作者：
Sanambar Sadighi
Mohammad Ali Mohagheghi
Ali Montazeri
Zahra Sadighi
机构：
[1] Tehran University of Medical Sciences,Cancer Research Center, Cancer Institute, Imam Hospital
[2] Iranian Institute for Health Sciences Research,undefined
来源：
BMC Cancer | / 6卷
关键词：
Gastric Cancer; Docetaxel; Epirubicin; Advanced Gastric Cancer; Group Physical Functioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
    Sadighi, Sanambar
    Mohagheghi, Mohammad Ali
    Montazeri, Ali
    Sadighi, Zahra
    [J]. BMC CANCER, 2006, 6 (1)
  • [2] Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma:: A randomised phase II study.
    Thuss-Patience, PC
    Kretzschmar, A
    Vielhaber, A
    Dörken, B
    Reichardt, P
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [3] A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
    Ducreux, M
    Rougier, P
    Pignon, JP
    Douillard, JY
    Seitz, JF
    Bugat, R
    Bosset, JF
    Merouche, Y
    Raoul, JL
    Ychou, M
    Adenis, A
    Berthault-Cvitkovic, F
    Luboinski, M
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (08) : 1185 - 1191
  • [4] Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma
    Lee, MA
    Woo, IS
    Kang, JH
    Hong, YS
    Lee, KS
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (06) : 346 - 350
  • [5] Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma
    Myung Ah Lee
    In Sook Woo
    Jin-Hyoung Kang
    Young Seon Hong
    Kyung Shik Lee
    [J]. Journal of Cancer Research and Clinical Oncology, 2004, 130 : 346 - 350
  • [6] Perioperative chemotherapy with epirubicin, cisplatin, and 5-FU (ECF) for gastroesophageal cancer: A retrospective analysis
    Bichev, D.
    Breithaupt, K.
    Dogan, Y.
    Grieser, C.
    Pfiffer, T. E.
    Daum, S.
    Treese, C.
    Schumacher, G.
    Doerken, B.
    Thuss-Patience, P. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] EPIRUBICIN, CISPLATIN AND INFUSIONAL 5-FLUOROURACIL (5-FU) (ECF) IN HEPATOBILIARY TUMORS
    ELLIS, PA
    NORMAN, A
    HILL, A
    OBRIEN, MER
    NICHOLSON, M
    HICKISH, T
    CUNNINGHAM, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1594 - 1598
  • [8] CISPLATIN, DOXORUBICIN, AND 5-FU IN COMBINATION FOR ADVANCED GASTRIC-CANCER
    VOGL, SE
    ENGSTROM, PF
    [J]. CANCER TREATMENT REPORTS, 1984, 68 (10): : 1273 - 1275
  • [9] Phase II trial of docetaxel and cisplatin in 5-FU/cisplatin pretreated refractory esophageal cancer
    Shim, H.
    Bae, W.
    Hwang, J.
    Cho, S.
    Nam, T.
    Chung, I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Interim safety results from a phase II/III trial with 5-FU, oxaliplatin, and docetaxel (FLOT) versus epirubicin, cisplatin, and 5-FU (ECF) in patients with locally advanced, resectable gastric/oesophagogastric junction (OGJ) cancer: A study of the AIO.
    Koock, Ulrike
    Pauligk, Claudia
    Luley, Kim Barbara
    Mayer, Frank
    Schulmann, Karsten
    Homann, Nils
    Schmalenberg, Harald
    Hozaeel, Wael
    Hofheinz, Ralf
    Probst, Stephan
    Mahlberg, Rolf
    Koenigsmann, Michael
    Haag, Georg Martin
    Meiler, Johannes
    Prasnikar, Nicole
    Behringer, Dirk M.
    Trojan, Jorg
    Egger, Matthias
    Jaeger, Elke
    Al-Batran, Salah-Eddin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345